Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check33 days agoChange DetectedUpdate to a citation: the reference moves from Online ahead of print (June 11, 2025) to a finalized in-issue version (June 11) and increments the revision/version from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check47 days agoChange DetectedUpdated from Revision v3.0.1 to v3.0.2, indicating a minor version update. The 'Back to Top' link was removed, while pricing, stock/availability, dates/times, and proper nouns remain unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe webpage has been updated to include new drug information and research studies related to Pembrolizumab and other treatments for non-small-cell lung cancer, while some previous content regarding specific drugs and related topics has been removed.SummaryDifference14%

- Check76 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.